Skip to main content
Paul Schulz, MD, Neurology, Houston, TX

Paul E. Schulz MD

Neurodegenerative, Dementia & Geriatrics


"Professor, Department of Neurology McGovern Medical School at UTHealth"

Join to View Full Profile
  • UT Physicians Neurocognitive Disorders1941 E Rd, Ste 4358Houston, TX 77054

  • Phone+1 713-486-0500

  • Fax+1 713-383-1435

Dr. Schulz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Paul Schulz is a neurologist at UTHealth Houston in Houston, TX. He received his medical degree from Boston University School of Medicine, did a residency in neurology and a fellowship in Cellular Neurophysiology, both at Baylor College of Medicine. He has been in practice for 37 years. He sees patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD), does medication clinical trials with that group, investigates mechanisms underlying MCI/AD, and investigates new diagnostic tools for them.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineResidency, Neurology, 1985 - 1988
  • Boston VA Healthcare System (Brockton-West Roxbury)
    Boston VA Healthcare System (Brockton-West Roxbury)Internship, Internal Medicine, 1984 - 1985
  • Boston University
    Boston UniversityB.A., Medical Sciences and Psychology, Magna Cum Laude, 1977 - 1984
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1984

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1988 - 2026
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • “Dean’s Excellence in Teaching Award” UTHealth, 2022
  • "Dean's Teaching Excellence Award" UTHealth, 2012
  • "Doctor's Choice" Health and Fitness Magazine, 2009
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Delirious Mania in Bipolar Disorder  
    Kimm, TS, Okusaga OO, and Schulz PE, Prim Care Companion CNS Disord, 1/2/2017
  • Hippocampal Sclerosis in Older Patients: Practical Examples and Guidance With a Focus on Cerebral Age-Related TDP-43 With Sclerosis  
    Cykowski MD, Powell SZ, Schulz PE, Takei H, Rivera AL, Jackson RE, Roman G, Jicha GA, and Nelson PT, Arch Pathol Lab Med, 1/1/2017
  • Neuropsychiatry  
    Arora G, Schulz PE, Neurology Secrets, 1/1/2017
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Deep Brain Stimulation of the Medial Forebrain Bundle: Significant Responses in Treatment Resistant Depression.
    Fenoy AJ, Schulz P, Selvaraj S, Burrows, Zunta-Soares G, Quevedo J, Soares JC, North American Neuromodulation Society (NANS) 21st Annual Meeting, Las Vegas, NV, 1/11/2018
  • Evidence for neuroinflammation in semantic dementia.
    Pascual MB, Roman GC, Yu M, Pal N, Rockers ED, Fregonara Z, Funk Q, Schulz PE, and Masdeu J, Human Amyloid Imaging Conference, 1/1/2018
  • Nonfluent variant of primary progressive aphasia: Tau deposition in the language network.
    Pascual B, Zanotti-Fregonara P, Funk Q, Rockers E, Pal N, Yu M, Spann B, Schulz P, Masdeu J, American Academy of Neurology (AAN) Meeting, 1/1/2017
  • Join now to see all

Lectures

  • "Lewy Body Dementia" 
    Austin, TX - 1/25/2017
  • "Update on Neuroimaging and Therapeutic Trials in Alzheimer's Disease" 
    Austin, TX - 1/25/2017
  • "Recent Advances in Diagnosing and Treating AD" 
    University of Texas Medical Branch, Galveston, TX - 1/22/2017
  • Join now to see all

Other

  • "Pimavanserin for Parkinson's Disease Psychosis." 
    Schulz PE, Webinar with Fort Worth MDs
    1/31/2017
  • Commenting on the radio on "It's impossible to ignore this anymore': CTE study details devastating toll on football players." 
    Schulz PE, News Talk 710 KURV
    TX - 1/26/2017
  • "Alzheimer's Day." 
    Schulz PE, KRUV Radio
    1/23/2017
  • Join now to see all

Press Mentions

  • Breakthrough Study Links Vaccines to Reduced Alzheimer’s Risk
    Breakthrough Study Links Vaccines to Reduced Alzheimer’s RiskJuly 5th, 2025
  • Getting This Shot Lowered Seniors’ Dementia Risk by 20%
    Getting This Shot Lowered Seniors’ Dementia Risk by 20%April 2nd, 2025
  • Groundbreaking Stem Cell Therapy Trial for Alzheimer's Disease Underway at UTHealth Houston
    Groundbreaking Stem Cell Therapy Trial for Alzheimer's Disease Underway at UTHealth HoustonMarch 13th, 2025
  • Join now to see all

Grant Support

  • Mechanisms underlying COVID-19 induced Neurocognitive DysfunctionUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2023–2028
  • Pilot Study--Amyloid Mediated ToxicityNational Institute On Aging1995–2000

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: